RenovoRx (RNXT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RNXT RenovoRx

Watchlist

1.035
-0.015-1.43%

Close Sep 26 16:00 ET

1.000
-0.035-3.38%

Post 16:17 ET

24.83MMarket Cap-1725P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully
Yahoo FinanceSep 26 07:29 ET
Express News | RenovoRx Increases Production of FDA-Cleared Renovocath® Delivery System in Response to Strong Demand From Oncology and Interventional Radiology Physicians
ReutersSep 25 08:30 ET
RenovoRx Announces Presentation At Symposium On Clinical Interventional Oncology Highlighting TAMP For Targeted Treatment Of Locally Advanced Pancreatic Cancer On Saturday, September 21, 2024
BenzingaSep 19 08:42 ET
Express News | RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting Tamp™ for Targeted Treatment of Locally Advanced Pancreatic Cancer
ReutersSep 19 08:30 ET
Ascendiant Maintains RenovoRx(RNXT.US) With Buy Rating, Raises Target Price to $8.25
Moomoo NewsSep 12 18:32 ET · Ratings
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday
BenzingaSep 12 08:21 ET

Comments

Jaguar8

Sep 19 07:32

NEWS

$RenovoRx (RNXT.US)$
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer
LOS ALTOS, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that Ripal Gandhi, M.D., FSIR, FSVM will present at the...

Jaguar8

Aug 14 12:05

NEWS

$RenovoRx (RNXT.US)$
RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
RenovoRx (Nasdaq: RNXT) has announced the enrollment of the first patient at the University of Nebraska Medical Center (UNMC) for its ongoing Phase III TIGeR-PaC clinical trial. The study is evaluating RenovoGem™, a novel therapy for Locally Advanced Pancreatic Cancer (LAPC) using the TAMP™ (Trans-Arterial Micro-Perfusion) platform....